nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—Carvedilol—HIF1A—pancreatic cancer	0.0549	0.713	CrCbGaD
Bevantolol—Carvedilol—VEGFA—pancreatic cancer	0.0221	0.287	CrCbGaD
Bevantolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.00095	0.00103	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.00095	0.00103	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IAPP—pancreatic cancer	0.00095	0.00103	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000945	0.00102	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000945	0.00102	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000944	0.00102	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DTX1—pancreatic cancer	0.000938	0.00102	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SSTR3—pancreatic cancer	0.000938	0.00102	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000931	0.00101	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000924	0.001	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000924	0.001	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000919	0.000995	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—SST—pancreatic cancer	0.000919	0.000995	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PTCH1—pancreatic cancer	0.000912	0.000988	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PTHLH—pancreatic cancer	0.000912	0.000988	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.00091	0.000986	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000901	0.000976	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SSTR1—pancreatic cancer	0.000899	0.000974	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000899	0.000974	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.00089	0.000964	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000889	0.000963	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PPY—pancreatic cancer	0.000882	0.000955	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000877	0.00095	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.000869	0.000942	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000866	0.000938	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000857	0.000929	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CNR1—pancreatic cancer	0.000848	0.000918	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.000842	0.000913	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.000842	0.000913	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000836	0.000906	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—SST—pancreatic cancer	0.000834	0.000904	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000832	0.000901	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000824	0.000893	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000824	0.000893	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000821	0.000889	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	0.000819	0.000887	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.000804	0.000871	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000797	0.000863	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000786	0.000852	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	0.000786	0.000852	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	0.000786	0.000852	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000783	0.000848	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000783	0.000848	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000783	0.000848	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000781	0.000846	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000775	0.00084	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.00077	0.000835	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	0.00077	0.000834	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000766	0.00083	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000766	0.00083	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000766	0.000829	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	0.000765	0.000828	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000765	0.000828	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000754	0.000816	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000747	0.000809	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	0.000743	0.000805	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000736	0.000798	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	0.000736	0.000797	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000731	0.000792	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.00072	0.00078	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	0.000719	0.000779	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000712	0.000772	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000709	0.000768	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000702	0.000761	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000698	0.000756	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000694	0.000752	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000687	0.000744	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000683	0.00074	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	0.000682	0.000738	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	0.000682	0.000738	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000679	0.000735	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000666	0.000721	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000666	0.000721	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000659	0.000714	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.000651	0.000706	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.000651	0.000706	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	0.00065	0.000704	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	0.000634	0.000686	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000634	0.000686	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000633	0.000686	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000623	0.000675	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	0.000609	0.00066	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	0.000604	0.000655	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000601	0.000651	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	0.000596	0.000646	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	0.000596	0.000645	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	0.000596	0.000645	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000593	0.000643	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000588	0.000637	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000583	0.000632	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000581	0.000629	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	0.000568	0.000616	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000565	0.000612	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	0.000562	0.000609	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	0.000561	0.000608	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	0.00055	0.000596	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000545	0.000591	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	0.000543	0.000588	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000539	0.000584	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000539	0.000584	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000534	0.000578	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	0.000531	0.000575	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000528	0.000572	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	0.000518	0.000561	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000517	0.00056	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	0.00051	0.000553	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	0.000507	0.000549	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	0.000499	0.000541	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SST—pancreatic cancer	0.000493	0.000534	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000486	0.000527	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	0.000482	0.000522	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.00048	0.00052	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000479	0.000519	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000469	0.000508	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00046	0.000499	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	0.000455	0.000493	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00045	0.000488	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	0.000447	0.000484	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000442	0.000479	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000441	0.000478	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	0.000439	0.000476	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	0.000437	0.000474	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	0.000436	0.000473	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000433	0.000469	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000427	0.000463	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	0.000427	0.000463	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000419	0.000454	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000418	0.000453	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	0.000413	0.000447	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000409	0.000443	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000402	0.000435	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000393	0.000426	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000388	0.00042	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	0.000382	0.000414	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	0.000374	0.000405	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000372	0.000403	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	0.000366	0.000396	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	0.000365	0.000395	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000362	0.000392	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000358	0.000388	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	0.000358	0.000388	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	0.000357	0.000387	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	0.000357	0.000387	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	0.000353	0.000383	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	0.00035	0.000379	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	0.000349	0.000378	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	0.000342	0.000371	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000338	0.000366	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000333	0.00036	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000329	0.000357	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000325	0.000353	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000325	0.000352	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000322	0.000349	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000322	0.000349	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	0.000322	0.000349	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	0.000318	0.000345	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000315	0.000341	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	0.000315	0.000341	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	0.000312	0.000338	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	0.000309	0.000335	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	0.000296	0.000321	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	0.000295	0.00032	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	0.000294	0.000318	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	0.000289	0.000313	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	0.000287	0.000311	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000283	0.000307	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	0.000283	0.000307	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000281	0.000304	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	0.000277	0.0003	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000277	0.0003	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000274	0.000297	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	0.000271	0.000294	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000269	0.000292	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000267	0.000289	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000261	0.000282	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	0.000261	0.000282	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	0.000258	0.000279	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000255	0.000276	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000249	0.00027	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000247	0.000267	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000242	0.000262	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	0.000238	0.000257	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	0.000237	0.000257	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	0.000236	0.000255	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	0.000232	0.000251	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	0.000231	0.00025	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000229	0.000248	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000229	0.000248	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	0.000227	0.000246	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000227	0.000246	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	0.000224	0.000243	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000224	0.000243	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	0.000222	0.000241	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	0.000221	0.000239	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	0.000219	0.000237	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	0.000216	0.000234	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	0.000215	0.000232	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000214	0.000232	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	0.000213	0.000231	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	0.00021	0.000227	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	0.000209	0.000226	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	0.000208	0.000225	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000206	0.000223	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	0.000204	0.000221	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	0.0002	0.000216	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	0.000198	0.000214	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	0.000194	0.00021	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	0.000193	0.000209	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	0.000192	0.000208	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	0.000191	0.000207	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	0.000191	0.000207	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	0.00019	0.000206	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	0.000189	0.000204	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	0.000187	0.000202	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	0.000186	0.000202	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	0.000185	0.000201	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	0.000184	0.000199	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	0.000179	0.000194	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	0.000177	0.000192	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000177	0.000192	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	0.000177	0.000192	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	0.000174	0.000188	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	0.000173	0.000188	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	0.000173	0.000188	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	0.000173	0.000187	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	0.000173	0.000187	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	0.00017	0.000184	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	0.000168	0.000182	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	0.000164	0.000177	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	0.00016	0.000174	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	0.00016	0.000173	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	0.000156	0.000169	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	0.000154	0.000167	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	0.000154	0.000167	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	0.000151	0.000163	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	0.000147	0.00016	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	0.000146	0.000158	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	0.000143	0.000155	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	0.000143	0.000155	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	0.000142	0.000154	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	0.00014	0.000152	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	0.000139	0.000151	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	0.000136	0.000148	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	0.000133	0.000144	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	0.000123	0.000133	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	0.000122	0.000132	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	0.00012	0.00013	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	0.000118	0.000128	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	0.000113	0.000122	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	9.95e-05	0.000108	CbGpPWpGaD
